INTERCEPT PHARMACEUTICALS, INC. (33)

Browse by Contract Category

Contracts

Security Agreement, dated as of August 17, 2021, among Intercept Pharmaceuticals, Inc., the Guarantors that may from time to time be a party thereto and U.S. Bank National... (Filed With SEC on August 23, 2021)
Employment Agreement, effective June 2, 2021, between the Registrant and M. Michelle Berrey (Filed With SEC on July 29, 2021)
Sumitomo Agreement, dated March 29, 2011, between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 25, 2021)
Commercial Manufacturing and Supply Agreement, dated August 12, 2016, between the Registrant and PharmaZell GMBH (Filed With SEC on February 25, 2021)
Third Amendment to Lease, dated November 1, 2019, between the Registrant and Legacy Yards Tenant LP (Filed With SEC on November 5, 2019)
First Supplemental Indenture, dated as of August 17, 2021, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee and as collateral agent (Filed With SEC on August 23, 2021)
Indenture, dated as of August 17, 2021, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee (Filed With SEC on August 23, 2021)
Employment Agreement, effective May 17, 2021, between the Registrant and Andrew Saik (Filed With SEC on July 29, 2021)
Employment Agreement, effective February 15, 2021, between the Registrant and Linda Richardson (Filed With SEC on May 6, 2021)
Employment Agreement, effective February 9, 2021, between the Registrant and Lisa DeFrancesco (Filed With SEC on May 6, 2021)
Employment Agreement, effective January 4, 2021, between the Registrant and Bryan Ball (Filed With SEC on May 6, 2021)
Employment Agreement, effective as of December 18, 2020, between the Registrant and Jared Freedberg (Filed With SEC on February 25, 2021)
Description of Securities of the Registrant (Filed With SEC on February 25, 2021)
Retirement and Consulting Agreement by and between Intercept Pharmaceuticals, Inc. and Mark Pruzanski, M.D., dated December 9, 2020 (Filed With SEC on December 10, 2020)
Amended and Restated Employment Agreement by and between Intercept Pharmaceuticals, Inc. and Jerome Durso, dated December 9, 2020 (Filed With SEC on December 10, 2020)
Form of Restricted Stock Unit Award Grant Notice and Agreement for Directors (Filed With SEC on August 10, 2020)
Employment Agreement, effective June 20, 2015, between the Registrant and Richard Kim (Filed With SEC on August 10, 2020)
Form of Stock Option Grant Notice and Agreement for Directors (Filed With SEC on August 10, 2020)
Letter Agreement, dated October 25, 2019, between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 25, 2020)
Employment Agreement, effective November 19, 2019, between the Registrant and Jason Campagna (Filed With SEC on February 25, 2020)
Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on February 25, 2020)
Form of Restricted Stock Unit Award Grant Notice and Agreement for Employees and Consultants (Filed With SEC on February 25, 2020)
Form of Stock Option Grant Notice and Agreement for Employees and Consultants (Filed With SEC on February 25, 2020)
Description of Securities of the Registrant (Filed With SEC on February 25, 2020)
Employment Agreement, effective February 6, 2018, between the Registrant and Gail Cawkwell (Filed With SEC on August 8, 2019)
Employment Agreement, effective January 22, 2018, between the Registrant and Ryan Sullivan (Filed With SEC on August 8, 2019)
Second Supplemental Indenture, dated as of May 14, 2019, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee (including the form of 2.00%... (Filed With SEC on May 14, 2019)
Securities Purchase Agreement, dated May 8, 2019, between Intercept Pharmaceuticals, Inc. and Samsara BioCapital, L.P (Filed With SEC on May 14, 2019)
Convertible Notes Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies... (Filed With SEC on May 14, 2019)
Common Stock Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies LLC,... (Filed With SEC on May 14, 2019)
Form of Restricted Stock Unit Grant Notice and Agreement for Employees and Consultants (Filed With SEC on May 8, 2019)
Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on May 8, 2019)
Form of Stock Option Grant Notice and Agreement for Employees and Consultants (Filed With SEC on May 8, 2019)